Want to join the conversation?
$AMGN said the U.S. FDA accepted for priority review the supplemental Biologics License Application for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric and adolescent patients with Philadelphia chromosomeâ??negative (Ph-) relapsed or refractory B-cell precurs acute lymphoblastic leukemia.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.